127 related articles for article (PubMed ID: 11258665)
1. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling.
Chao J; Miao RQ; Chen V; Chen LM; Chao L
Biol Chem; 2001 Jan; 382(1):15-21. PubMed ID: 11258665
[TBL] [Abstract][Full Text] [Related]
2. Biochemistry, regulation and potential function of kallistatin.
Chao J; Chao L
Biol Chem Hoppe Seyler; 1995 Dec; 376(12):705-13. PubMed ID: 9072045
[TBL] [Abstract][Full Text] [Related]
3. Kallistatin is a potent new vasodilator.
Chao J; Stallone JN; Liang YM; Chen LM; Wang DZ; Chao L
J Clin Invest; 1997 Jul; 100(1):11-7. PubMed ID: 9202051
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation.
Wang CR; Chen SY; Wu CL; Liu MF; Jin YT; Chao L; Chao J
Arthritis Rheum; 2005 Apr; 52(4):1319-24. PubMed ID: 15818689
[TBL] [Abstract][Full Text] [Related]
5. Kallistatin in blood pressure regulation transgenic and somatic gene delivery studies.
Chao J; Chao L
Trends Cardiovasc Med; 1997 Nov; 7(8):307-11. PubMed ID: 21235901
[TBL] [Abstract][Full Text] [Related]
6. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery.
Miao RQ; Murakami H; Song Q; Chao L; Chao J
Circ Res; 2000 Mar; 86(4):418-24. PubMed ID: 10700446
[TBL] [Abstract][Full Text] [Related]
7. Kallistatin is a new inhibitor of angiogenesis and tumor growth.
Miao RQ; Agata J; Chao L; Chao J
Blood; 2002 Nov; 100(9):3245-52. PubMed ID: 12384424
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats.
Chen LM; Chao L; Chao J
Hum Gene Ther; 1997 Feb; 8(3):341-7. PubMed ID: 9048201
[TBL] [Abstract][Full Text] [Related]
9. Tissue kallikrein inhibitors in mammals.
Chao J; Chai KX; Chao L
Immunopharmacology; 1996 May; 32(1-3):67-72. PubMed ID: 8796269
[TBL] [Abstract][Full Text] [Related]
10. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.
Chen VC; Chao L; Chao J
J Biol Chem; 2000 Dec; 275(49):38457-66. PubMed ID: 10993887
[TBL] [Abstract][Full Text] [Related]
11. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence.
Zhou GX; Chao L; Chao J
J Biol Chem; 1992 Dec; 267(36):25873-80. PubMed ID: 1334488
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.
Gao G; Shao C; Zhang SX; Dudley A; Fant J; Ma JX
Diabetologia; 2003 May; 46(5):689-98. PubMed ID: 12743698
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation.
Devani M; Vecchi M; Ferrero S; Avesani EC; Arizzi C; Chao L; Colman RW; Cugno M
Dig Liver Dis; 2005 Sep; 37(9):665-73. PubMed ID: 15949977
[TBL] [Abstract][Full Text] [Related]
14. Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
Wolf WC; Harley RA; Sluce D; Chao L; Chao J
J Histochem Cytochem; 1999 Feb; 47(2):221-8. PubMed ID: 9889257
[TBL] [Abstract][Full Text] [Related]
15. Structural elements of kallistatin required for inhibition of angiogenesis.
Miao RQ; Chen V; Chao L; Chao J
Am J Physiol Cell Physiol; 2003 Jun; 284(6):C1604-13. PubMed ID: 12734113
[TBL] [Abstract][Full Text] [Related]
16. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney.
Chen LM; Song Q; Chao L; Chao J
Kidney Int; 1995 Sep; 48(3):690-7. PubMed ID: 7474653
[TBL] [Abstract][Full Text] [Related]
17. Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli.
Chai KX; Chen LM; Chao J; Chao L
J Biol Chem; 1993 Nov; 268(32):24498-505. PubMed ID: 8227002
[TBL] [Abstract][Full Text] [Related]
18. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein.
Chen VC; Chao L; Chao J
J Biol Chem; 2000 Dec; 275(51):40371-7. PubMed ID: 10991942
[TBL] [Abstract][Full Text] [Related]
19. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
Stadnicki A; Mazurek U; Plewka D; Wilczok T
Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of kallistatin expression in rheumatoid joints.
Wang CR; Chen SY; Shiau AL; Wu CL; Jou IM; Chao L; Chao J
J Rheumatol; 2007 Nov; 34(11):2171-6. PubMed ID: 17937475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
